Prot #TAK-012-1501: A Phase 1/2a, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety and Efficacy of GDX012 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Project: Research project

Project Details

Effective start/end date11/14/2311/14/26


  • PPD Investigator Services, LLC (Prot # TAK-012-1501 // Prot # TAK-012-1501)
  • Takeda Development Center Americas, Inc. (Prot # TAK-012-1501 // Prot # TAK-012-1501)